Q4 2025 Holdings
Filed 2026-02-12 | 7 holdings | $151.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc.(GLUE) | Common Stock | 61225M102 | $68.7M | 4,382,687 | 45.5% |
| Lenz Therapeutics, Inc.(LENZ) | Common Stock | 52635N103 | $42.5M | 2,656,888 | 28.1% |
| Jade Biosciences, Inc.(JBIO) | Common Stock | 008064206 | $23.5M | 1,525,820 | 15.6% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $7.8M | 148,831 | 5.2% |
| Contineum Therapeutics, Inc.(CTNM) | Common Stock | 21217B100 | $6.2M | 542,628 | 4.1% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $1.5M | 2,007,704 | 1.0% |
| Tempest Therapeutics, Inc.(OVASUSD) | Common Stock | 87978U108 | $774.2K | 269,772 | 0.5% |